STERIS PLC (NYSE:STE) Expected to Announce Earnings of $0.80 Per Share
Brokerages expect STERIS PLC (NYSE:STE) to report earnings per share of $0.80 for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for STERIS PLC’s earnings, with the highest EPS estimate coming in at $0.82 and the lowest estimate coming in at $0.79. STERIS PLC posted earnings of $0.79 per share in the same quarter last year, which indicates a positive year over year growth rate of 1.3%. The business is expected to issue its next quarterly earnings results before the market opens on Tuesday, August 8th.
On average, analysts expect that STERIS PLC will report full-year earnings of $4.06 per share for the current year, with EPS estimates ranging from $4.05 to $4.08. For the next year, analysts expect that the firm will post earnings of $4.53 per share, with EPS estimates ranging from $4.51 to $4.57. Zacks’ earnings per share calculations are a mean average based on a survey of analysts that follow STERIS PLC.
STERIS PLC (NYSE:STE) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 EPS for the quarter, beating the Zacks’ consensus estimate of $0.80 by $0.05. STERIS PLC had a net margin of 4.20% and a return on equity of 11.12%. The business had revenue of $608 million during the quarter, compared to analysts’ expectations of $597.66 million. During the same period in the prior year, the company earned $0.79 earnings per share. The firm’s revenue was down 4.8% on a year-over-year basis.
Several analysts have commented on STE shares. BidaskClub cut shares of STERIS PLC from a “strong-buy” rating to a “buy” rating in a research note on Monday, July 31st. Zacks Investment Research raised shares of STERIS PLC from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a report on Tuesday, July 11th. Wellington Shields lowered shares of STERIS PLC from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Finally, KeyCorp raised shares of STERIS PLC from a “sector weight” rating to an “overweight” rating and set a $89.00 price target for the company in a report on Wednesday, May 3rd. Two analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. STERIS PLC has an average rating of “Buy” and an average target price of $84.00.
Shares of STERIS PLC (NYSE:STE) traded up 5.70% during mid-day trading on Tuesday, hitting $86.90. 616,796 shares of the stock were exchanged. The stock’s 50-day moving average price is $82.15 and its 200-day moving average price is $74.62. STERIS PLC has a 52-week low of $63.80 and a 52-week high of $87.49. The company has a market cap of $7.39 billion, a P/E ratio of 67.89 and a beta of 1.33.
COPYRIGHT VIOLATION NOTICE: “STERIS PLC (NYSE:STE) Expected to Announce Earnings of $0.80 Per Share” was originally reported by Daily Political and is owned by of Daily Political. If you are viewing this piece on another site, it was copied illegally and republished in violation of United States and international trademark and copyright laws. The correct version of this piece can be viewed at https://www.dailypolitical.com/2017/08/08/steris-plc-nyseste-expected-to-announce-earnings-of-0-80-per-share.html.
In other news, Director Michael B. Wood sold 4,000 shares of the company’s stock in a transaction on Monday, July 3rd. The shares were sold at an average price of $81.50, for a total transaction of $326,000.00. Following the completion of the sale, the director now owns 26,131 shares of the company’s stock, valued at $2,129,676.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the company’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $80.05, for a total transaction of $800,500.00. The disclosure for this sale can be found here. Insiders have sold 30,340 shares of company stock valued at $2,432,704 in the last ninety days. Insiders own 2.55% of the company’s stock.
Several large investors have recently added to or reduced their stakes in STE. Janus Capital Management LLC raised its stake in STERIS PLC by 0.4% in the first quarter. Janus Capital Management LLC now owns 8,669,694 shares of the medical equipment provider’s stock worth $602,192,000 after buying an additional 33,758 shares during the last quarter. Wellington Management Group LLP raised its stake in STERIS PLC by 77.8% in the first quarter. Wellington Management Group LLP now owns 6,529,610 shares of the medical equipment provider’s stock worth $453,547,000 after buying an additional 2,856,744 shares during the last quarter. Legato Capital Management LLC raised its stake in STERIS PLC by 6,926.1% in the first quarter. Legato Capital Management LLC now owns 5,944,248 shares of the medical equipment provider’s stock worth $85,578,000 after buying an additional 5,859,646 shares during the last quarter. BlackRock Inc. raised its stake in STERIS PLC by 16,597.1% in the first quarter. BlackRock Inc. now owns 5,272,105 shares of the medical equipment provider’s stock worth $366,200,000 after buying an additional 5,240,530 shares during the last quarter. Finally, FMR LLC raised its stake in STERIS PLC by 9.6% in the first quarter. FMR LLC now owns 2,595,305 shares of the medical equipment provider’s stock worth $180,270,000 after buying an additional 226,303 shares during the last quarter. 91.80% of the stock is owned by institutional investors and hedge funds.
About STERIS PLC
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for STERIS PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS PLC and related companies with MarketBeat.com's FREE daily email newsletter.